BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Fuji
Express Scripts
Cerilliant
McKesson
Merck
Mallinckrodt
Covington
Farmers Insurance
Medtronic

Generated: January 17, 2018

DrugPatentWatch Database Preview

Paliperidone - Generic Drug Details

« Back to Dashboard

What are the generic sources for paliperidone and what is the scope of paliperidone patent protection?

Paliperidone
is the generic ingredient in four branded drugs marketed by Janssen Pharms, Actavis Labs Fl Inc, and Mylan Pharms Inc, and is included in five NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-four drug master file entries for paliperidone. Ten suppliers are listed for this compound.
Pharmacology for paliperidone

US Patents and Regulatory Information for paliperidone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms INVEGA SUSTENNA paliperidone palmitate SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 022264-002 Jul 31, 2009 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Janssen Pharms INVEGA SUSTENNA paliperidone palmitate SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 022264-005 Jul 31, 2009 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Janssen Pharms INVEGA TRINZA paliperidone palmitate SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 207946-004 May 18, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Janssen Pharms INVEGA paliperidone TABLET, EXTENDED RELEASE;ORAL 021999-006 Aug 26, 2008 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Janssen Pharms INVEGA SUSTENNA paliperidone palmitate SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 022264-001 Jul 31, 2009 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE;ORAL 203802-004 Sep 24, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Labs Fl Inc PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE;ORAL 202645-004 Aug 3, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Labs Fl Inc PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE;ORAL 202645-002 Aug 3, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Janssen Pharms INVEGA TRINZA paliperidone palmitate SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 207946-001 May 18, 2015 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Mylan Pharms Inc PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE;ORAL 203802-002 Sep 24, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for paliperidone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms INVEGA paliperidone TABLET, EXTENDED RELEASE;ORAL 021999-004 Dec 19, 2006 ➤ Subscribe ➤ Subscribe
Janssen Pharms INVEGA paliperidone TABLET, EXTENDED RELEASE;ORAL 021999-006 Aug 26, 2008 ➤ Subscribe ➤ Subscribe
Janssen Pharms INVEGA paliperidone TABLET, EXTENDED RELEASE;ORAL 021999-001 Dec 19, 2006 ➤ Subscribe ➤ Subscribe
Janssen Pharms INVEGA paliperidone TABLET, EXTENDED RELEASE;ORAL 021999-003 Dec 19, 2006 ➤ Subscribe ➤ Subscribe
Janssen Pharms INVEGA paliperidone TABLET, EXTENDED RELEASE;ORAL 021999-002 Dec 19, 2006 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
US Army
Farmers Insurance
Baxter
Cerilliant
Fish and Richardson
Colorcon
Deloitte
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot